Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

2.

A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.

Pey R, Bach J, Schieren G, Gretz N, Hafner M.

In Vitro Cell Dev Biol Anim. 1999 Nov-Dec;35(10):571-9.

PMID:
10614866
3.

Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat.

Harpur E, Ennulat D, Hoffman D, Betton G, Gautier JC, Riefke B, Bounous D, Schuster K, Beushausen S, Guffroy M, Shaw M, Lock E, Pettit S; HESI Committee on Biomarkers of Nephrotoxicity.

Toxicol Sci. 2011 Aug;122(2):235-52. doi: 10.1093/toxsci/kfr112. Epub 2011 May 18.

4.

Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.

Meijer E, Boertien WE, Nauta FL, Bakker SJ, van Oeveren W, Rook M, van der Jagt EJ, van Goor H, Peters DJ, Navis G, de Jong PE, Gansevoort RT.

Am J Kidney Dis. 2010 Nov;56(5):883-95. doi: 10.1053/j.ajkd.2010.06.023.

PMID:
20888104
5.

Renal concentration of alpha-tocopherol: dependence on gender and lack of effect on polycystic kidney disease in Han:SPRD rats.

Torres VE, Bengal RJ, Nickander KK, Grande JP, Low PA.

Am J Kidney Dis. 1998 Apr;31(4):687-93.

PMID:
9531187
6.

Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats.

Tonomura Y, Tsuchiya N, Torii M, Uehara T.

Toxicology. 2010 Jun 29;273(1-3):53-9. doi: 10.1016/j.tox.2010.04.015. Epub 2010 May 10.

PMID:
20438795
7.
8.

Evaluation of novel renal biomarkers with a cisplatin model of kidney injury: gender and dosage differences.

Pinches M, Betts C, Bickerton S, Burdett L, Thomas H, Derbyshire N, Jones HB, Moores M.

Toxicol Pathol. 2012 Apr;40(3):522-33. doi: 10.1177/0192623311432438.

9.

Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).

Wahl PR, Serra AL, Le Hir M, Molle KD, Hall MN, Wüthrich RP.

Nephrol Dial Transplant. 2006 Mar;21(3):598-604. Epub 2005 Oct 12.

10.

The effect of paclitaxel on the progression of polycystic kidney disease in rodents.

Martinez JR, Cowley BD, Gattone VH 2nd, Nagao S, Yamaguchi T, Kaneta S, Takahashi H, Grantham JJ.

Am J Kidney Dis. 1997 Mar;29(3):435-44.

PMID:
9041221
11.

Altered organic anion and osmolyte content and excretion in rat polycystic kidney disease: an NMR study.

Ogbron MR, Sareen S, Prychitko J, Buist R, Peeling J.

Am J Physiol. 1997 Jan;272(1 Pt 2):F63-9.

PMID:
9039050
12.
13.

Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.

Tao Y, Kim J, Faubel S, Wu JC, Falk SA, Schrier RW, Edelstein CL.

Proc Natl Acad Sci U S A. 2005 May 10;102(19):6954-9. Epub 2005 Apr 29.

14.

Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury.

Hauet T, Baumert H, Gibelin H, Hameury F, Goujon JM, Carretier M, Eugene M.

Cryobiology. 2000 Dec;41(4):280-91.

PMID:
11222025
15.

Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.

Gile RD, Cowley BD Jr, Gattone VH 2nd, O'Donnell MP, Swan SK, Grantham JJ.

Am J Kidney Dis. 1995 Sep;26(3):501-7.

PMID:
7645559
16.

Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats.

Wang X, Zhang S, Liu Y, Spichtig D, Kapoor S, Koepsell H, Mohebbi N, Segerer S, Serra AL, Rodriguez D, Devuyst O, Mei C, Wüthrich RP.

Kidney Int. 2013 Nov;84(5):962-8. doi: 10.1038/ki.2013.199. Epub 2013 May 29.

PMID:
23715121
17.

Urinary excretion of glutathione S transferases alpha and pi in patients with proteinuria: reflection of the site of tubular injury.

Branten AJ, Mulder TP, Peters WH, Assmann KJ, Wetzels JF.

Nephron. 2000 Jun;85(2):120-6.

PMID:
10867517
18.

Urinary collagen IV and πGST: potential biomarkers for detecting localized kidney injury in diabetes--a pilot study.

Cawood TJ, Bashir M, Brady J, Murray B, Murray PT, O'Shea D.

Am J Nephrol. 2010;32(3):219-25. doi: 10.1159/000317531. Epub 2010 Jul 20.

PMID:
20664197
19.
20.

Renal function and arterial blood pressure alterations after exposure to acetaminophen with a potential role of Nigella sativa oil in adult male rats.

Ahmed OG, El-Mottaleb NA.

J Physiol Biochem. 2013 Mar;69(1):1-13. doi: 10.1007/s13105-012-0182-y. Epub 2012 Jun 23.

PMID:
22730078
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk